Hepatitis after Konyne administration.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001779:Blood Coagulation Factors / Q000009:adverse effects*; D002648:Child; D005164:Factor IX / Q000009:adverse effects; D005167:Factor VII / Q000009:adverse effects; D005170:Factor X / Q000009:adverse effects; D005260:Female; D002836:Hemophilia B / Q000150:complications / Q000188:drug therapy; D006506:Hepatitis A / Q000097:blood / Q000209:etiology* / Q000401:mortality; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D008107:Liver Diseases / Q000150:complications; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011041:Poisoning / Q000150:complications; D011516:Prothrombin / Q000009:adverse effects; D014859:Warfarin / Q000506:poisoning
D001779:Blood Coagulation Factors; D006511:Hepatitis B Antigens; D014859:Warfarin; D005167:Factor VII; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin